Azumino, Japan

Kiyoshi Kasai




Average Co-Inventor Count = 4.4

ph-index = 1


Location History:

  • Fukui, JP (2002 - 2007)
  • Niigata, JP (2009)
  • Joetsu, JP (2010 - 2011)
  • Azumino, JP (2015 - 2017)

Company Filing History:


Years Active: 2002-2017

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Kiyoshi Kasai: Innovator in Pharmaceutical Compounds

Introduction

Kiyoshi Kasai is a prominent inventor based in Azumino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target dopamine receptors. With a total of 7 patents to his name, his work is crucial in advancing treatments for neurological disorders.

Latest Patents

Among his latest patents, Kiyoshi Kasai has focused on providing novel compounds that exhibit agonistic effects on dopamine receptors. One of his inventions includes a compound represented by a specific general formula, which is designed to treat or prevent conditions such as Parkinson's disease. This compound, along with its pharmaceutically acceptable salts, demonstrates potent dopamine receptor simulating activities. Another notable patent involves octahydrothienoquinoline derivatives, which also exhibit significant dopamine receptor stimulating activities and are included in pharmaceutical compositions for therapeutic use.

Career Highlights

Kiyoshi Kasai is currently associated with Kissei Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in creating effective treatments for various neurological conditions, showcasing his expertise in medicinal chemistry.

Collaborations

Kiyoshi has collaborated with notable colleagues such as Junichi Sonehara and Toshihiro Nishimura. These collaborations have further enhanced the research and development efforts within the pharmaceutical industry.

Conclusion

Kiyoshi Kasai's contributions to the field of pharmaceuticals, particularly in developing dopamine receptor-targeting compounds, highlight his role as a leading inventor. His ongoing work at Kissei Pharmaceutical Co., Ltd. continues to pave the way for innovative treatments in neurology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…